Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Bloomberg

BusinessBloomberg·Sep 8, 2026·1 min read

Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers

On this episode of Stock Movers: - Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. - Boston Scientific (BSX) shares…

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Pharma major plummets over 10% after third trial disappointment in a week

BusinessSep 8, 2026 · 1 min

Pharma major plummets over 10% after third trial disappointment in a week

BusinessSep 3, 2026 · 1 min

Nvidia Up on Acquisition; Snowflake Jumps on Outlook | Stock Movers

BusinessSep 8, 2026 · 1 min

European Stocks Muted as Novartis Shares Fall Most on Record

BusinessSep 8, 2026 · 1 min

Novartis Sees Avidity Drug Suffer Third Clinical-Trial Setback